Minerva Neurosciences, Inc. (NERV) Debt Components
- 2018-06-30: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $1.40M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m).
- 2018-03-31: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $2.70M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m).
- 2017-12-31: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $3.96M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m).
- 2017-09-30: Convertible Notes Payable, CurrentUSD (m); Notes Payable, CurrentUSD $5.19M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m).
Minerva Neurosciences, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Notes Payable, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-term Debt, Gross USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | (m) | $1.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $2.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $3.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $5.19M | (m) | (m) | (m) | (m) | (m) | (m) | $4.76M | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $5.07M | (m) | (m) | (m) | (m) | (m) | (m) | $6.00M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $4.96M | (m) | (m) | (m) | (m) | (m) | (m) | $7.23M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $4.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $8.43M | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $4.75M | (m) | (m) | (m) | (m) | (m) | (m) | $9.61M | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $3.88M | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $2.64M | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $1.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $251.59K | (m) | (m) | $0.00 | $1.57M | $4.94M | $3.49M | $10.00M | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $1.09M | (m) | (m) | $0.00 | $3.14M | $4.02M | $2.84M | $10.00M | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $158.26K | $-158.26K | $9.55M | (m) | $3.14M | $4.02M | $2.84M | $10.00M | (m) | (m) | (m) | $294.88K |
| 2014-07-07 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) | 6.00 | (m) |
| 2014-06-30 | $2.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.97M | (m) | (m) |
| 2013-12-31 | $58.27K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.97M | (m) | (m) | (m) | $1.94M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |